Diagonal Bio AB (OSTO:DIABIO) Additional Paid-In Capital : kr57.25 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Diagonal Bio AB Additional Paid-In Capital?

Diagonal Bio AB's quarterly additional paid-in capital increased from Jun. 2023 (kr56.13 Mil) to Sep. 2023 (kr57.25 Mil) but then stayed the same from Sep. 2023 (kr57.25 Mil) to Dec. 2023 (kr57.25 Mil).

Diagonal Bio AB's annual additional paid-in capital increased from Dec. 2021 (kr45.20 Mil) to Dec. 2022 (kr56.18 Mil) and increased from Dec. 2022 (kr56.18 Mil) to Dec. 2023 (kr57.25 Mil).

Diagonal Bio AB Additional Paid-In Capital Historical Data

The historical data trend for Diagonal Bio AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagonal Bio AB Additional Paid-In Capital Chart

Diagonal Bio AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

9.44

45.20

56.18

57.25

Diagonal Bio AB Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial									45.14	56.18	56.13	57.25	57.25

Diagonal Bio AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Diagonal Bio AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Diagonal Bio AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagonal Bio AB (OSTO:DIABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diagonal Bio AB (OSTO:DIABIO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

9F1:Germany

Address

The Spark, Medicon Village, Lund, SWE, 223 81

Website

https://www.diagonalbio.com

Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.

Diagonal Bio AB (OSTO:DIABIO) Headlines

No Headlines